A detailed history of Forvis Wealth Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Forvis Wealth Advisors, LLC holds 2,386 shares of AMGN stock, worth $702,748. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,386
Previous 1,705 39.94%
Holding current value
$702,748
Previous $532,000 44.36%
% of portfolio
0.02%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$309.38 - $337.38 $210,687 - $229,755
681 Added 39.94%
2,386 $768,000
Q2 2024

Aug 09, 2024

SELL
$262.75 - $319.31 $163,956 - $199,249
-624 Reduced 26.79%
1,705 $532,000
Q1 2024

Apr 19, 2024

SELL
$268.87 - $324.56 $66,948 - $80,815
-249 Reduced 9.66%
2,329 $662,000
Q4 2023

Jan 11, 2024

BUY
$255.7 - $288.46 $8,949 - $10,096
35 Added 1.38%
2,578 $742,000
Q3 2023

Oct 25, 2023

BUY
$218.65 - $271.46 $137,968 - $171,291
631 Added 33.0%
2,543 $683,000
Q2 2023

Aug 08, 2023

BUY
$214.27 - $253.37 $113,134 - $133,779
528 Added 38.15%
1,912 $424,000
Q1 2023

Apr 26, 2023

BUY
$225.79 - $275.2 $11,966 - $14,585
53 Added 3.98%
1,384 $334,000
Q4 2022

Feb 02, 2023

BUY
$229.03 - $291.01 $19,238 - $24,444
84 Added 6.74%
1,331 $349,000
Q3 2022

Oct 13, 2022

SELL
$224.46 - $253.15 $31,873 - $35,947
-142 Reduced 10.22%
1,247 $281,000
Q2 2022

Jul 22, 2022

BUY
$230.71 - $256.74 $38,067 - $42,362
165 Added 13.48%
1,389 $338,000
Q1 2022

May 10, 2022

BUY
$219.27 - $242.57 $60,518 - $66,949
276 Added 29.11%
1,224 $296,000
Q4 2021

Jan 14, 2022

BUY
$198.88 - $227.6 $188,538 - $215,764
948 New
948 $213,000
Q2 2021

Jul 14, 2021

SELL
$233.58 - $259.14 $319,537 - $354,503
-1,368 Closed
0 $0
Q1 2021

Apr 23, 2021

SELL
$221.91 - $258.6 $819,291 - $954,751
-3,692 Reduced 72.96%
1,368 $340,000
Q4 2020

Jan 22, 2021

BUY
$216.38 - $257.67 $95,856 - $114,147
443 Added 9.59%
5,060 $1.16 Million
Q3 2020

Nov 05, 2020

BUY
$234.65 - $260.95 $36,840 - $40,969
157 Added 3.52%
4,617 $1.17 Million
Q2 2020

Jul 15, 2020

BUY
$197.81 - $242.74 $19,781 - $24,274
100 Added 2.29%
4,460 $1.05 Million
Q1 2020

Apr 10, 2020

BUY
$182.24 - $241.7 $10,752 - $14,260
59 Added 1.37%
4,360 $884,000
Q4 2019

Jan 13, 2020

BUY
$189.21 - $243.2 $84,009 - $107,980
444 Added 11.51%
4,301 $1.04 Million
Q3 2019

Oct 29, 2019

BUY
$174.11 - $208.62 $32,036 - $38,386
184 Added 5.01%
3,857 $746,000
Q2 2019

Jul 10, 2019

BUY
$166.7 - $195.41 $16,336 - $19,150
98 Added 2.74%
3,673 $677,000
Q1 2019

Apr 10, 2019

SELL
$180.87 - $203.88 $82,657 - $93,173
-457 Reduced 11.33%
3,575 $679,000
Q4 2018

Jan 15, 2019

BUY
$178.4 - $208.25 $26,760 - $31,237
150 Added 3.86%
4,032 $785,000
Q3 2018

Oct 09, 2018

SELL
$185.29 - $208.89 $5,558 - $6,266
-30 Reduced 0.77%
3,882 $805,000
Q2 2018

Jul 13, 2018

BUY
$166.05 - $186.51 $9,630 - $10,817
58 Added 1.5%
3,912 $722,000
Q1 2018

May 25, 2018

BUY
$169.43 - $198.0 $3,896 - $4,554
23 Added 0.6%
3,854 $657,000
Q1 2018

Apr 20, 2018

SELL
$169.43 - $198.0 $11,351 - $13,266
-67 Reduced 1.72%
3,831 $671,000
Q4 2017

Jan 18, 2018

BUY
$168.79 - $188.59 $34,601 - $38,660
205 Added 5.55%
3,898 $678,000
Q3 2017

Oct 13, 2017

BUY
$167.29 - $191.0 $617,801 - $705,363
3,693
3,693 $689,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Forvis Wealth Advisors, LLC Portfolio

Follow Forvis Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Forvis Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Forvis Wealth Advisors, LLC with notifications on news.